Zhang et al. carried out chromatin immunoprecipitation assays to evaluate ARID1A promoter histone modification levels in breast cancer samples and reported methylation of histone H3 at lysine 27 was linked to ARID1A silencing [17]. Here, ARID1A is linked to breast carcinoma.